News

31 August 2017
medwireNews: Neonatal diabetes could be detected as early as day 5 of life using glucose measurements from dried blood spots, researchers report. “Earlier diagnosis by systematic screening could lead to prompt genetic diagnosis and targeted treatment, thereby avoiding the most severe sequelae of hyperglycaemia in neonates”, say Timothy... Read More
31 August 2017
medwireNews: The Infacort® hydrocortisone preparation of taste-masked granules can be used in children of all ages, including neonates, report researchers. Infacort® (Diurnal Limited, Cardiff, UK) has undergone an as yet unpublished phase III trial in Europe, and the manufacturer submitted it for European marketing authorisation at the end of... Read More
31 August 2017
medwireNews: Findings from the real-world NordiNet® International Outcome Study demonstrate clear benefits of early diagnosis and treatment initiation in patients with isolated growth hormone deficiency (GHD). However, Michel Polak (Hôpital Universitaire Necker Enfants Malades, Paris, France) and study co-authors stress that all patients... Read More
28 July 2017
medwireNews: Session attendance was only moderate and self-monitoring very poor in youths with type 2 diabetes who participated in the TODAY lifestyle programme, an analysis shows. “Given the salience of program attendance and self-monitoring to lifestyle weight management established in other populations, future research is needed to... Read More
28 July 2017
medwireNews: Updated guidelines for the management of patients with Turner syndrome (TS) have been published, marking the first multi-society recommendations for the condition. The guidelines were developed through meetings initiated by the European Society of Endocrinology and by the Pediatric Endocrine Society in the USA, followed by a... Read More
28 July 2017
medwireNews: Data from a dose-escalation study of the long-acting growth hormone (GH) somapacitan support its further development as a weekly treatment in children with GH deficiency (GHD), say researchers. The medication, which is currently being tested in a phase III trial in adults and a phase II trial in children, reversibly binds to... Read More